Showing all 4 results
Isosorbide Mononitrate Tablets
FreeProduct Composition & Strength
We supply this product as Immediate Release Tablets (20 mg). We also offer Extended Release (ER/SR) variants for once-daily dosing through our contract manufacturing division.
Active Ingredient Strength (Standard) Therapeutic Role Isosorbide Mononitrate BP/USP 20 mg Organic Nitrate / Vasodilator Excipients Q.S. Microcrystalline Cellulose / Lactose Stabilizing Matrix Nicorandil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Shielded Tablet, packed exclusively in highly secure, heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of the highly volatile active ingredient.
Active Ingredient Strength Primary Clinical Function Nicorandil Ph.Eur./BP 5 mg Initiation / Titration Standard: Base therapeutic unit for the mandatory slow-titration protocol required to build patient tolerance and prevent severe “nitrate headaches.” Nicorandil Ph.Eur./BP 10 mg / 20 mg Global Cardiology Standard: High-dose adult maintenance therapy for severe, refractory stable angina pectoris. Excipients Maize Starch / Croscarmellose Sodium / Stearic Acid / Mannitol Low-Moisture Diluent / Superdisintegrant / Lubricant (Engineered specifically without hygroscopic binders to guarantee the tablet remains perfectly dry and structurally intact throughout its shelf life) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict chronic cardiology dispensing regimens).
Nitroglycerin Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Concentrate for Infusion in glass ampoules or vials. (Must be diluted).
Active Ingredient Strength Total Content Nitroglycerin USP/BP 5 mg/ml 25 mg (in 5 ml Ampoule) Nitroglycerin USP/BP 5 mg/ml 50 mg (in 10 ml Vial) Excipients Propylene Glycol / Ethanol Solubilizers (Volatile) *Pack Sizes: Tray of 5 Ampoules or 10 Vials.
Trimetazidine Tablets
FreeProduct Composition & Strength
We supply this product as an advanced Modified-Release (MR) Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the stability of both the active ingredient and the kinetic polymer matrix.
Active Ingredient Strength Primary Clinical Use Trimetazidine Dihydrochloride BP/Ph.Eur. 35 mg (Modified-Release) Global Standard: Twice-daily maintenance therapy for stable angina pectoris. Trimetazidine Dihydrochloride BP/Ph.Eur. 20 mg (Immediate-Release) Three-times-daily dosing for specialized dose titration or specific regional protocols. Excipients Hypromellose (HPMC) / Calcium Hydrogen Phosphate / Magnesium Stearate SR Polymer Matrix / Diluent / Lubricant (Engineered for strict 12-hour kinetic release)
